Lykos Therapeutics Announces FDA Acceptance
The FDA has granted the application priority review and has assigned a Prescription Drug User Fee Act (PDUFA) target action date of August 11, 2024.
Global Pharma | 10/02/2024 | By Manvi | 694
Zynex Receives FDA Clearance for Next-Gen M-Wave Neuromuscular Stimulation Device
The M-Wave, successor to the renowned E-Wave, revolutionizes NMES treatments with enhanced functionality and a user-friendly design.
Global Pharma | 08/02/2024 | By Manvi | 1362
Sibel Health's ANNE One Receives 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring
This latest clearance expands the capabilities of the ANNE® One platform to include continuous ambulatory ECG monitoring, SpO2, temperature, and non-invasive blood pressure measurements.
Global Pharma | 08/02/2024 | By Manvi | 1087
Thermax Acquires TSA Process Equipments
Thermax has signed definitive agreements for acquisition to be completed in due course and will fully acquire the balance stake of the company over the next two years.
Global Pharma | 07/02/2024 | By Manvi | 817
AstraZeneca Invests USD 300 Million in Cutting-Edge Cell Therapy Facility in Rockville, MD
The site, strategically located within Maryland's flourishing life sciences corridor and near universities, underscores AstraZeneca's commitment to innovation and talent recruitment.
Global Pharma | 07/02/2024 | By Manvi | 439
Empower Pharma Acquires East Windsor Facility for Pharmaceutical Expansion
The companies anticipate completing the transaction in the coming months, subject to the satisfaction of closing conditions.
Global Pharma | 07/02/2024 | By Manvi | 595
The distribution agreement includes KRONOS products for Brenntag Specialties’ customers in Life Science segments, which include pharmaceutical as well as cosmetics and personal care applications.
Global Pharma | 06/02/2024 | By Manvi | 288
Zuellig Pharma Expands Healthcare Portfolio with Acquisition of Cialis and Alimta Brands
The acquisition covers Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, and Thailand through its wholly-owned subsidiary, Zanovex Pte. Ltd.
Global Pharma | 05/02/2024 | By Manvi | 1800
Aurobindo Pharma's US Subsidiary Eugia to Sell Business Assets for USD 52 Million
The agreement encompasses Eugia's related assets, liabilities, and employees, as the company strategically focuses on enhancing capacities and operations in other units.
Global Pharma | 05/02/2024 | By Manvi | 1265
Gericke Announces Inauguration of its New Production Hall in Switzerland
The state-of-the-art facility marks a significant milestone in the company's commitment to meeting the growing demand for leading-edge technology in the powder processing industry.
Global Pharma | 03/02/2024 | By Manvi | 459
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy